Browsing by Author "Goracinova, Katerina"
Now showing items 1-4 of 4
-
Design of ophthalmic micelles loaded with diclofenac sodium: effect of chitosan and temperature on the block-copolymer micellization behaviour
Koummich, Sarra Aicha; Zoukh, Ikram Mustapha; Gorachinov, Filip; Geskovski, Nikola; Makreski, Petre; Dodov, Marija Glavas; Goracinova, Katerina... more authors ... less authors ( Springer , 2022 , Article)Diclofenac sodium 0.1% is a commonly used NSAID with well-documented clinical efficacy in reducing postoperative inflammation; however, its corneal tolerability and ophthalmic tissue bioavailability require further ... -
The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
Geskovski, Nikola; Matevska-Geshkovska, Nadica; Sazdovska, Simona Dimchevska; Dodov, Marija Glavas; Mladenovska, Kristina; Goracinova, Katerina... more authors ... less authors (2021 , Article)Nanomedicine has emerged as a novel cancer treatment and diagnostic modality, whose design constantly evolves towards increasing the safety and efficacy of the chemotherapeutic and diagnostic protocols. Molecular diagnostics, ... -
Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer
Gorachinov, Filip; Mraiche, Fatima; Moustafa, Diala Alhaj; Hishari, Ola; Ismail, Yomna; Joseph, Jensa; Crcarevska, Maja Simonoska; Dodov, Marija Glavas; Geskovski, Nikola; Goracinova, Katerina... more authors ... less authors ( Beilstein-Institut Zur Forderung der Chemischen Wissenschaften , 2023 , Article)Genomic and proteomic mutation analysis is the standard of care for selecting candidates for therapies with tyrosine kinase inhibitors against the human epidermal growth factor receptor (EGFR TKI therapies) and further ... -
Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model.
Al-Thani, Hissa F; Shurbaji, Samar; Zakaria, Zain Zaki; Hasan, Maram H; Goracinova, Katerina; Korashy, Hesham M; Yalcin, Huseyin C... more authors ... less authors ( MDPI , 2022 , Article)Tyrosine kinase inhibitors (TKIs) are the new generation of anti-cancer drugs with high potential against cancer cells' proliferation and growth. However, TKIs are associated with severe cardiotoxicity, limiting their ...